Novel prostaglandin I2 derivative

Details for Australian Patent Application No. 2009292555 (hide)

Owner Asahi Glass Company, Limited Kaken Pharmaceutical Co., Ltd.

Inventors Murata, Takahiko; Amakawa, Masahiro; Teradaira, Shin; Matsumura, Yasushi; Konishi, Katsuhiko

Agent Griffith Hack

Pub. Number AU-A-2009292555

PCT Pub. Number WO2010/029925

Priority 2008-232133 10.09.08 JP; 2009-168193 16.07.09 JP

Filing date 8 September 2009

Wipo publication date 18 March 2010

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/5585 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/029925 Priority application(s): WO2010/029925

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009292594-Solar cell module, installation structure for solar cell module, and installation method for solar cell module

2009292542-Gaming machine of reduced installation area and improved visibility